ArticleThe EMBO journal2021
PRMT1 promotes the tumor suppressor function of p14
Open access · hybridAbstract read
In one paragraph
Article in The EMBO journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.
0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed, 40 citations in OpenAlex.
- Small-Molecule Activators of PRMT1: Discovery, SAR Analyses, and Proapoptotic Effects in Pancreatic Cancer Cells.Journal of medicinal chemistry · 2026Article
- Post-Translational Modifications in Pancreatic Cancer: Mechanisms to Clinical Applications.Journal of gastroenterology and hepatology · 2026Review
- A suite of macrocyclic peptide inhibitors and substrate probes for arginine methyltransferases.Chemical science · 2026Article
- Protein arginine methyltransferases in cancer: mechanisms, functions, and therapeutic opportunities.Journal of biomedical science · 2026Review
- Review
- ENY2 transcription and export complex 2 subunit deficiency induces nucleolar stress to inhibit tumor progression through NPM1/MDM2/p53-dependent and -independent responses.Cellular oncology (Dordrecht, Netherlands) · 2026Article
- Targeting the PRMT1 axis in cancer: from epigenetic plasticity to contextual therapeutic interventions.Frontiers in oncology · 2026Review
- Nuclear-Cytoplasmic Axis in Cancer: From Protein Mislocalization to Anticancer Drug Resistance.Oncology research · 2026Review
- Arginine methylation in cancer: mechanisms and therapeutic implications.Biomarker research · 2025Review
- The Role of Protein Arginine Methylation as a Post-Translational Modification in Cellular Homeostasis and Disease.Biology · 2025Review
- Nonchromatin regulatory functions of the histone variant H2A.B in SWI/SNF genomic deposition.Science advances · 2025Article
- Regulation of protein arginine methyltransferase in osteoporosis: a narrative review.Frontiers in cell and developmental biology · 2025Review
- Polydopamine Nanoparticle-Based Combined Chemotherapy and Photothermal Therapy for the Treatment of Liver Cancer.ACS applied materials & interfaces · 2024Article
- SRY-Box transcription factor 9 triggers YAP nuclear entry via direct interaction in tumors.Signal transduction and targeted therapy · 2024Article
- Elongin B promotes breast cancer progression by ubiquitinating tumor suppressor p14/ARF.Cell biology and toxicology · 2024Article
- PRMT1 Sustains De Novo Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer.Cancer research · 2024Article
- PRMT1 promotes pancreatic cancer development and resistance to chemotherapy.Cell reports. Medicine · 2024Article
- PRMT1-mediated PGK1 arginine methylation promotes colorectal cancer glycolysis and tumorigenesis.Cell death & disease · 2024Article
- PRMT1 in human neoplasm: cancer biology and potential therapeutic target.Cell communication and signaling : CCS · 2024Review
- Targeting the PRMT1-cGAS-STING signaling pathway to enhance the anti-tumor therapeutic efficacy.Journal of cancer biology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors at 3 institutions in 1 country.
Antje RepenningInstitute for Molecular Biology and Tumor Research (IMT), Philipps-University Marburg, Marburg, Germany.
Daniela HappelInstitute for Molecular Biology and Tumor Research (IMT), Philipps-University Marburg, Marburg, Germany.
Caroline BouchardInstitute for Molecular Biology and Tumor Research (IMT), Philipps-University Marburg, Marburg, Germany.
Marion MeixnerInstitute for Molecular Biology and Tumor Research (IMT), Philipps-University Marburg, Marburg, Germany.
Yesim Verel-YilmazDepartment of Visceral, Thoracic and Vascular Surgery, University Hospital Marburg, Philipps-University Marburg, Marburg, Germany.
Hartmann RaiferCore Facility Flow Cytometry, University Hospital Marburg, Philipps-University Marburg, Marburg, Germany.
Lena HolembowskiInstitute for Molecular Biology and Tumor Research (IMT), Philipps-University Marburg, Marburg, Germany.
Eberhard KrauseLeibniz Institute of Molecular Pharmacology, Berlin, Germany.
Elisabeth KremmerInstitute of Molecular Immunology, Helmholtz Zentrum München, German Research Center for Environmental Health, München, Germany.
Regina FeederleMonoclonal Antibody Core Facility, Institute for Diabetes and Obesity, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.ORCID 0000-0002-3981-367X
Corinna U KeberInstitute for Pathology, University Hospital Marburg, Philipps-University Marburg, Marburg, Germany.
Michael LohoffInstitute for Med. Microbiology & Hospital Hygiene, University Hospital Marburg, Philipps-University Marburg, Marburg, Germany.
Emily P SlaterDepartment of Visceral, Thoracic and Vascular Surgery, University Hospital Marburg, Philipps-University Marburg, Marburg, Germany.
Detlef K BartschDepartment of Visceral, Thoracic and Vascular Surgery, University Hospital Marburg, Philipps-University Marburg, Marburg, Germany.
Uta-Maria BauerInstitute for Molecular Biology and Tumor Research (IMT), Philipps-University Marburg, Marburg, Germany.ORCID 0000-0003-1344-9117
Philipps University of Marburg · DEHelmholtz Zentrum München · DELeibniz Association · DE
Funding
No grant is acknowledged in the PubMed record.
Abstract
The p14
Indexed as
AnimalsApoptosisCell CycleCell LineCell Line, TumorCell NucleolusCell NucleusHEK293 CellsHeLa CellsHumansNeoplasm ProteinsNuclear ProteinsPancreatic NeoplasmsPrognosisProtein-Arginine N-MethyltransferasesRepressor ProteinsNeoplasm ProteinsNuclear ProteinsPRMT1 protein, humanProtein-Arginine N-MethyltransferasesRepressor ProteinsTumor Suppressor Protein p14ARFTumor Suppressor Protein p53apoptosisarginine methylationpancreatic cancerpost-translational modificationtumor suppression
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.